ARCHIVES

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

This article is from The Cancer Letter archive.

Vol. 39 No. 30 | July 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

NCI-Approved Clinical Trials Listed For January

January 28, 2005

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Otis Brawley To Succeed Harmon Eyre As American Cancer Society’s Chief Medical Officer.

August 3, 2007

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991